Cellebrite DI Ltd. (NASDAQ:CLBT) Position Increased by Quadrature Capital Ltd

Quadrature Capital Ltd raised its position in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 96.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 256,402 shares of the company's stock after purchasing an additional 125,913 shares during the period. Quadrature Capital Ltd owned 0.12% of Cellebrite DI worth $2,222,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently modified their holdings of the company. Parallel Advisors LLC increased its position in shares of Cellebrite DI by 75.0% in the 4th quarter. Parallel Advisors LLC now owns 3,500 shares of the company's stock valued at $30,000 after purchasing an additional 1,500 shares during the last quarter. Quarry LP acquired a new position in shares of Cellebrite DI in the 4th quarter valued at $36,000. Central Asset Investments & Management Holdings HK Ltd acquired a new position in shares of Cellebrite DI in the 4th quarter valued at $113,000. Hennessy Advisors Inc. acquired a new position in shares of Cellebrite DI in the 4th quarter valued at $131,000. Finally, New York State Common Retirement Fund boosted its holdings in shares of Cellebrite DI by 166.0% in the 3rd quarter. New York State Common Retirement Fund now owns 15,440 shares of the company's stock valued at $118,000 after buying an additional 9,635 shares in the last quarter. 45.88% of the stock is owned by hedge funds and other institutional investors.

Cellebrite DI Price Performance

Shares of CLBT stock traded down $0.26 during mid-day trading on Tuesday, hitting $11.98. The stock had a trading volume of 1,445,314 shares, compared to its average volume of 942,533. Cellebrite DI Ltd. has a fifty-two week low of $6.08 and a fifty-two week high of $12.67. The firm has a market cap of $2.47 billion, a PE ratio of -20.66, a PEG ratio of 1.65 and a beta of 1.48. The company's 50-day simple moving average is $11.09 and its 200-day simple moving average is $10.30.

Cellebrite DI (NASDAQ:CLBT - Get Free Report) last released its earnings results on Thursday, May 23rd. The company reported $0.08 EPS for the quarter, topping the consensus estimate of $0.06 by $0.02. Cellebrite DI had a negative net margin of 32.57% and a positive return on equity of 417.94%. The company had revenue of $89.60 million during the quarter, compared to analysts' expectations of $85.34 million. During the same quarter last year, the business earned $0.03 EPS. The business's revenue was up 25.8% on a year-over-year basis. On average, analysts expect that Cellebrite DI Ltd. will post 0.34 EPS for the current year.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the stock. Craig Hallum upped their target price on shares of Cellebrite DI from $14.00 to $16.00 and gave the company a "buy" rating in a report on Monday, April 1st. Lake Street Capital initiated coverage on shares of Cellebrite DI in a report on Friday, April 19th. They issued a "buy" rating and a $13.00 target price for the company. William Blair upgraded shares of Cellebrite DI from a "market perform" rating to an "outperform" rating in a research note on Wednesday, March 13th. Bank of America increased their price target on shares of Cellebrite DI from $12.00 to $13.00 and gave the stock a "buy" rating in a research note on Monday, April 1st. Finally, JPMorgan Chase & Co. increased their price target on shares of Cellebrite DI from $12.00 to $14.00 and gave the stock an "overweight" rating in a research note on Friday, May 24th. Six analysts have rated the stock with a buy rating, According to MarketBeat, the stock presently has an average rating of "Buy" and an average target price of $13.17.

About Cellebrite DI

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.